THU, MARCH 18, 2022 14:50 CET
BPC Instruments presented the company’s solid business case and future plans at Aktiedagen Stockholm on 14th March. CEO Dr. Jing Liu attended the event and presented the company’s latest financial figures which show that BPC continues to be a solid, stable, and profitable company with good business growth despite the challenges of a recent global pandemic over the past two years. Furthermore, BPC also talked about its current market and future plans to enter new business segments within the biotech field and presented the company’s latest flagship product BPC® GO, which is assessed to increase the total addressable market for BPC and attract new customer groups for wider applications.
The presentation from 14th March is available at this link.
CEO Interview with Börsvärlden
In connection with the publishing of the Company’s year-end report, CEO Dr. Jing Liu was interviewed by the Swedish financial newspaper Börsvärlden and discussed BPC’s future plans, solid business growth, as well as shareholder expectation of the Company.
“Our main goal is for our instruments to solve our customer’s working challenges, and we will keep on investing in innovation and providing time-saving and cost-efficient analytical solutions to several biotechnology segments including renewable energy, biodegradability, animal feed, and wastewater” said CEO Dr. Jing Liu when commenting on the Company’s vision.
The interview with Börsvärlden is available at this link.